Zoom In on Dementia & Alzheimer's

Zoom In on Dementia & Alzheimer's is a monthly virtual discussion series with world-class expert research scientists to keep you informed about the latest breakthroughs and findings in the field—from treatments and genetics to risk reduction, supplements, and more.


Each session will include a live Q&A where you can ask your questions directly of the experts. All sessions will be recorded and available to watch on demand.

Zoom in on Dementia & Alzheimer's - A free virtual discussion with medical experts.

Register for upcoming Zoom In on Dementia & Alzheimer's programs

A older couple sitting on a sofa and smiling while looking at a laptop computer.

Brain Health Research: Participate From Your Home

Clinical Research

Tuesday, June 18, 2024
1:00 pm EST (please adjust for your time zone)

James J. Lah, MD, PhD
Alice and Roy Richards Professor of Neurology and Director of the Emory Cognitive Neurology Program at Emory University Brain Health Center
John Showalter, MD
Chief Product Officer and Chief Strategy Officer at Linus Health


MRI image of a brain injury.

The Role of Genetics in Early Diagnosis and Treatment of Dementia

Thursday, June 20, 2024
1:00 pm EST (please adjust for your time zone)




Previous Episodes

Timothy J. Hohman, PhD
May 16, 2024

Are AI programs the next frontier in forecasting, understanding, and managing Alzheimer’s? Dr. Timothy Hohman gives us the scoop on all things AI and dementia.


Gil Rabinovici, MD
April 18, 2024

Distinguished Alzheimer’s expert Dr. Gil Rabinovici explains how early-onset Alzheimer’s is recognized, diagnosed, and treated and what separates it from the most common form of the disease.


Laura Baker, PhD
March 21, 2024

An international brain health expert helps to decipher the best evidence-based lifestyle strategies for protecting your brain as you age.


Marwan Noel Sabbagh MD, FAAN
February 15, 2024

Listen to world-renowned Alzheimer’s expert Dr. Marwan Sabbagh as he guides us through the complex stages and progression of Alzheimer’s and helps us understand the resources available at each stage.



Jeffrey Cummings, MD, ScD
January 25, 2024

In 2023, there were 184 trials assessing 143 drugs for the treatment of Alzheimer's disease (AD) and Mild Cognitive Impairment, with more than 60,000 participants required to populate those registered trials at 5684 sites. What is happening in 2024? Find out with Dr. Jeffrey Cummings for the insider’s overview.


Reisa Sperling, MD
November 16, 2023

Three new drugs for Alzheimer’s disease have been approved, and pharmaceutical companies are currently testing 141 Alzheimer’s drugs in 178 clinical trials. World-renowned expert Dr. Reisa Sperling discusses what might be coming through the treatment pipeline for dementias within the next three years.


Richard S. Isaacson, MD
October 19, 2023

There is no wonder drug or miracle cure for Alzheimer’s and related dementias, but research studies show that lifestyle choices can cut down your risk. Join Dr. Richard S. Isaacson as he shares insights on how preventative lifestyle changes and individualized care can meaningfully reduce your dementia risk and benefit your overall health.


Randall Bateman, MD
September 25, 2023

From written evaluations to blood tests, retinal and brain scans, AI-based wearable technologies, and everything in between, Dr. Randall J. Bateman takes a deep dive into the latest and greatest methods that can lead to earlier detection of dementias.


Cynthia Lemere, PhD
July 27, 2023

Join Dr. Cynthia Lemere, Scientist at Brigham and Women’s Hospital and Associate Professor of Neurology at Harvard Medical School, and host Nancy Lynn of BrightFocus Foundation for a discussion on the rapidly evolving—and complex—landscape of available treatments for Alzheimer’s disease and ask the experts what this means for you or a family member.


This program is supported in part by educational funding provided by:

Biogen logo Eli Lilly logo Genentech logo

BrightFocus Foundation is dedicated to reaching millions of people worldwide through its public outreach and education efforts around brain and eye health.